REFERENCIAS
Carlson, A.L. et al. 97-P- Safety and glycaemic outcomes of the MiniMed™ AHCL System in subjects with T1D. 80th ADA International Conference, June 2020, Chicago
Collyns .O. et al. 199-OR- Improved glycaemic Outcomes with MiniMed™ AHCL Delivery. 80th
ADA International Conference, June 2020, Chicago
Dados da Medtronic em arquivo. MRM 17430 MiniMed™ Mio™ Advance claims from Human
Factors Testing
Dados da Medtronic em arquivo IFU Comparison versus MiniMed Quick Set
Dados da Medtronic em arquivo. Ensaio principal (idades 14 – 75). N=157. 2020; 16 locais nos EUA
Bergenstal, R. M. et al. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes Jama. 2016; 316 (13): 1407 – 1408
Battelino T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care 2019; 42(8): 1593-1603.